FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Charles University in Prague
Praga, República ChecaPublicaciones en colaboración con investigadores/as de Charles University in Prague (8)
2023
-
Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
Frontiers in Pharmacology, Vol. 14
2021
-
High soluble endoglin levels affect aortic vascular function during mice aging
Journal of Cardiovascular Development and Disease, Vol. 8, Núm. 12
2020
-
Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts
PLoS ONE, Vol. 15, Núm. 5
-
Soluble endoglin as a potential biomarker of nonalcoholic steatohepatitis (Nash) development, participating in aggravation of nash-related changes in mouse liver
International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-19
2019
-
Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies
Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824
-
High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice
Life Sciences, Vol. 232
2018
-
Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta
Atherosclerosis, Vol. 271, pp. 15-25
2017
-
High soluble endoglin levels do not induce changes in structural parameters of mouse heart
Heart and Vessels, Vol. 32, Núm. 8, pp. 1013-1024